Key Takeaways Doctors in Shanghai transplanted stem cell derived islet tissue into a man with type 2 diabetes in 2019. The patient stopped using insulin injections within eleven weeks and stayed insulin-free for years afterward. A separate 2026 study used the same method in three patients with type 1 diabetes,
Key Takeaways Chronic, low-grade inflammation and insulin resistance drive each other in a two-way loop that starts largely in visceral fat. Mesenchymal stem cells are being studied for their ability to calm this inflammation and support insulin sensitivity, not to replace diet, exercise, or medication. A 2022 randomized trial found
Quick Summary In 2026, stem cell therapy for diabetes shows measurable improvement in 60-80% of patients, including better blood sugar control, reduced insulin use, and improved insulin resistance. Type 2 diabetes patients often respond better than type 1. However, full remission remains uncommon, and results depend on disease duration, treatment
